IvyRock Asset Management »

Intellia Therapeutics shares owned by IvyRock Asset Management

Quarter-by-quarter ownership of Intellia Therapeutics (NTLA) shares owned by IvyRock Asset Management from 13F filings

Historical chart of IvyRock Asset Management investment in Intellia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Intellia Therapeutics held by IvyRock Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intellia Therapeutics by IvyRock Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $248k 14k 17.27

More positions owned by IvyRock Asset Management

Pdd Holdings Sponsored Ads (PDD)
Legend Biotech Corp Sponsored Ads (LEGN)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Alibaba Group Hldg Sponsored Ads (BABA)
Ishares Ethereum Tr SHS (ETHA)
Zai Lab Adr (ZLAB)
Spdr Gold Tr Gold Shs (GLD)
Bloom Energy Corp Com Cl A (BE)
Direxion Shs Etf Tr Daily S&p Biotch (LABU)
So Young International Sponsored Ads (SY)
Microsoft Corporation (MSFT)
Arrowhead Pharmaceuticals (ARWR)
Advanced Micro Devices (AMD)
Cisco Systems (CSCO)
Intellia Therapeutics (NTLA)

View all positions for IvyRock Asset Management

Top funds holding Intellia Therapeutics

ARK Investment Management
Vanguard Group
BlackRock
Contrarius Group Holdings
State Street Corporation
Goldman Sachs Group
Morgan Stanley
Regeneron Pharmaceuticals
Baker Bros. Advisors
Geode Capital Management
Two Sigma Investments
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
D. E. Shaw & Co
Two Sigma Advisers

View all funds holding Intellia Therapeutics